Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1019 of 5804
-
New therapy combo aims to keep women in opioid recovery
Disease control Recruiting nowUsing a hybrid type 1 effectiveness-implementation approach, this study aims to evaluate the impact of a novel stepped care model ("PCT+2HOPE") versus treatment as usual (TAU) on increasing retention in community-based medication for opioid use disorder (MOUD) treatment among wom…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can patients stop Anti-Rejection drugs sooner after transplant?
Disease control Not yet recruitingThe purpose of this study is to test the feasibility and safety of early cessation of tacrolimus following allogeneic hematopoietic cell transplantation (HCT). Post-HCT tacrolimus is given to prevent graft-vs-host-disease (GVHD), but with the use of post-transplant cyclophosphami…
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for rare bleeding disorder: coagadex trial targets AL amyloidosis
Disease control TerminatedThe purpose of this study is to evaluate the efficacy and safety of Coagadex in treating active bleeds and to manage peri-operative bleeding in participants with acquired factor X deficiency associated with AL amyloidosis.
Phase: PHASE3 • Sponsor: Kedrion S.p.A. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Nano drug aims to boost appetite and weight in pancreatic cancer patients
Symptom relief Recruiting nowCancer anorexia-cachexia syndrome is a common and severe complication in patients with advanced cancer, with a particularly high prevalence in pancreatic cancer. It is associated with systemic inflammation, metabolic disturbances, and dysregulation of central appetite control, le…
Phase: NA • Sponsor: Shandong Cancer Hospital and Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New hope for ITP patients: switching drugs after failed treatment
Disease control Not yet recruitingThis study is a prospective, multicenter, randomized controlled study, planning to enroll 110 ITP patients who failed to respond to conventional-dose rhTPO (300 IU/kg/d) after 14 days of treatment (PLT \< 30×10⁹/L). After a 2-week washout period, they will be randomized to the rh…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Brain tumor surgery: new drug may cut stroke risk
Disease control Not yet recruitingPrevious studies have shown that the incidence of postoperative stroke, particularly covert stroke, is high following brain tumor resection and is closely associated with inflammatory responses and disruption of the blood-brain barrier. Ulinastatin, a broad-spectrum protease inhi…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New antibody therapy aims to tame lupus in early trial
Disease control Not yet recruitingBudoprutug is a humanized, immunoglobulin (Ig) G1 monoclonal antibody that selectively binds to CD19 and is projected to deplete targeted cells through antibody-dependent cellular cytotoxicity. This Phase 1b/2a, open-label study will evaluate budoprutug in ascending dose cohorts …
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New blood test may spot hidden pancreatic cancer earlier after surgery
Knowledge-focused Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) carries one of the worst prognoses among solid tumors. Even after curative-intent resection, 70-80% of patients recur within two years. Current post-operative surveillance relies on computed tomography (CT) imaging and the serum tumor marke…
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New drug SKB118 aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB118 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can simulated High-Altitude breathing boost lung cancer treatment?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding intermittent hypoxic training (IHT) to standard neoadjuvant chemo-immunotherapy can increase the pathologic complete response (pCR) rate in patients aged 18 to 75 of both sexes with resectable stage II-IIIA lung squamous cell …
Phase: PHASE2 • Sponsor: zhang yi • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy aims to tackle tough bone cancer
Disease control Not yet recruitingThis is a single-center, single-arm, prospective observational study to evaluate the long-term local control rate, safety, and efficacy of preoperative neoadjuvant radiotherapy (36-45 Gy) followed by sequential radical surgery and postoperative chemotherapy in patients with high-…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug aims to stop nosebleeds in rare blood vessel disorder
Disease control Not yet recruitingThis is a 2-part study evaluating ATV-1601 in participants with moderate to severe HHT. Part 1 is a randomized, double-blind, placebo-controlled study evaluating 3 dosing regimens of ATV-1601. Patients completing Part 1 may participate in the Part 2 open-label extension to receiv…
Phase: PHASE1, PHASE2 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a muscle relaxant lift depression? new trial underway
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a drug called TNX-102 SL works to treat moderate to severe major depressive disorder in adults. It will also learn about the safety of TNX-102 SL. The main questions it aims to answer are: Does TNX-102 SL improve depression symptoms…
Phase: PHASE2 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Five sessions to save lives: new therapy targets suicidal teens
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the Ultra-Brief Interpersonal Psychotherapy for Adolescents with Suicidal Ideation (IPT-A-SCI) works to reduce suicidal thoughts and behaviors in children and adolescents. The study will also examine whether treatment effects continu…
Phase: NA • Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New digital program aims to ease migraine pain without drugs
Symptom relief Recruiting nowThis study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exercise therapy, and a dedicated care team, in reducing migraine frequency among a…
Phase: NA • Sponsor: Hinge Health, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New MRI-Guided brain zaps aim to ease anxiety in days
Symptom relief Not yet recruitingGeneralized Anxiety Disorder (GAD) is a common psychiatric disorder associated with persistent anxiety, functional impairment, and incomplete response to existing treatments. Although transcranial magnetic stimulation (TMS) has shown therapeutic potential in anxiety disorders, co…
Phase: NA • Sponsor: Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
AI reads CT scans to predict which lung nodules turn cancerous
Knowledge-focused Not yet recruitingPulmonary ground-glass nodules (GGNs) are commonly found on chest CT scans. Some stay stable for years, while others slowly or rapidly turn into lung cancer. Doctors currently follow these nodules with repeated CT scans, but it is difficult to tell ahead of time which nodules wil…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThe purpose of this clinical trial is to learn how well ACT-777991 works, how safe it is and how well it is tolerated by adults with non-segmental vitiligo. The main question this clinical trial aims to answer is: • Can ACT-777991 help return color to the skin of the face of ad…
Phase: PHASE2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a simple breathing workout boost heart failure Patients' stamina?
Symptom relief Not yet recruitingHeart failure is frequently associated with inspiratory muscle weakness, which contributes to dyspnea, reduced exercise capacity, impaired quality of life, and adverse cardiovascular outcomes. Although inspiratory muscle training (IMT) is a recommended adjunct to cardiovascular r…
Phase: NA • Sponsor: Universidad Nacional Andres Bello • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a tiny ear device ease severe PMS and menopause symptoms?
Symptom relief Recruiting nowTranscutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the in…
Phase: NA • Sponsor: Texas Christian University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC